The Blood Transfusion Diagnostics Market is valued at around USD 4.73 billion in 2022 and is expected to reach USD 8.7 billion by 2030, registering a CAGR of 7% over the forecast period. Transfusion of blood is the process of giving blood—either as a whole or as a component of blood—by intravenous means to another person. Red blood cells, white blood cells, platelets, plasma, and clotting factors are all parts of blood. Before being given from one person to another, blood must be examined because it could transmit an infection or blood-borne diseases like post-transfusion purpura, anaphylaxis, delayed hemolytic reactions, and febrile non-hemolytic reactions. Read More: https://wemarketresearch.com/reports/blood-transfusion-diagnostics-market/776/